A Polish radio piece on the oral version of Wegovy and its results for weight loss. The listing carries no figures or other details beyond the topic.
Recap by typeshit. Full story at www.polskieradio.pl.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Alessandro Sette's lab will track T cell responses in people before and after starting GLP-1s, including to Parkinson's-linked proteins. He is enrolling himself too.
12:35
Dr. Eric Berg walks through the basics of peptides in a broad explainer. Treat any health claims as his own views.
A post from @macroglide puts the Ozempic and Wegovy maker's US-listed stock at under $35 in 2026, down from roughly $144 at its high.
The Partnership for Safe Medicines calls the compounding illegal and risky, as RFK Jr. pitches a state-regulated marketplace for peptides like BPC-157, per RAPS.
Loading…